Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
26856 | 200 | 41.7 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANGIOTENSIN CONVERTING ENZYME 1 | Author keyword | 1 | 50% | 1% | 2 |
2 | ANTI THY11 | Author keyword | 1 | 50% | 1% | 1 |
3 | KNOWLEDGE TRANSFER TRANSLATION | Author keyword | 1 | 50% | 1% | 1 |
4 | MOL BIOL SURG | Address | 1 | 50% | 1% | 1 |
5 | MONOCYTE CHEMOATTRACTANT PEPTIDE MCP 1 | Author keyword | 1 | 50% | 1% | 1 |
6 | PURSLANE PORTULACA OLERACEA | Author keyword | 1 | 50% | 1% | 1 |
7 | RENAL TIGHT JUNCTIONS | Author keyword | 1 | 50% | 1% | 1 |
8 | TUBB 3 | Author keyword | 1 | 50% | 1% | 1 |
9 | ANIMAL MODELS OF HUMAN DISEASES | Author keyword | 0 | 33% | 1% | 1 |
10 | BIONANOSCI BIO IMAGING PROGRAM | Address | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLOMERULAR DAMAGE | 1 | 14% | 4% | 7 |
2 | TRANSCRIPTION FACTOR KLF5 BTEB2 | 1 | 40% | 1% | 2 |
3 | INCREASE CALCIUM REABSORPTION | 1 | 50% | 1% | 1 |
4 | LIPASE LPL | 1 | 50% | 1% | 1 |
5 | TGF BETA 2 EXPRESSION | 1 | 50% | 1% | 1 |
6 | 2 CONSECUTIVE INJECTIONS | 0 | 33% | 1% | 1 |
7 | ANTITHROMBOXANE AGENT | 0 | 33% | 1% | 1 |
8 | DEPENDENT CHEMOTAXIS | 0 | 33% | 1% | 1 |
9 | INDUCED NEPHRITIS | 0 | 33% | 1% | 1 |
10 | NEPHRON DEVELOPMENT | 0 | 33% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Retinoid metabolism and its effects on the vasculature | 2012 | 12 | 151 | 20% |
The Controversial Role of Retinoic Acid in Fibrotic Diseases: Analysis of Involved Signaling Pathways | 2013 | 6 | 66 | 18% |
Retinoic acid regulation of mesangial cell apoptosis | 2002 | 13 | 22 | 41% |
Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention? | 2008 | 4 | 74 | 32% |
Retinoids - Versatile biological response modifiers of vascular smooth muscle phenotype | 2000 | 37 | 100 | 20% |
Retinoid and TGF-beta Families: Crosstalk in Development, Neoplasia, Immunity, and Tissue Repair | 2012 | 8 | 91 | 11% |
Retinoic acid and the heart | 2007 | 36 | 135 | 7% |
Retinoids and arterial smooth muscle cells | 2000 | 15 | 99 | 13% |
Retinoids and cell growth in the cardiovascular system | 1999 | 5 | 40 | 18% |
Progression of renal disease: new insights into risk factors and pathomechanisms | 2004 | 14 | 59 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL BIOL SURG | 1 | 50% | 0.5% | 1 |
2 | BIONANOSCI BIO IMAGING PROGRAM | 0 | 33% | 0.5% | 1 |
3 | CHEM BIOL PHYSICOCHEM | 0 | 33% | 0.5% | 1 |
4 | MCCOY DIABET MASS SPE OMETRY | 0 | 33% | 0.5% | 1 |
5 | MOL PHYSIOL CELLULAR BIOPHYS | 0 | 33% | 0.5% | 1 |
6 | MOL MED PHYSIOL PATHOPHYSIOL | 0 | 25% | 0.5% | 1 |
7 | BIOMED DIAGNOST PROGRAM | 0 | 11% | 1.0% | 2 |
8 | CLIN COOPERAT GRP AEROSOLS MED | 0 | 20% | 0.5% | 1 |
9 | MEDGLOMERULAR BIOENGN UNIT | 0 | 20% | 0.5% | 1 |
10 | NANO BIOENGN EDUC PROGRAM | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179820 | ESTUDOS EST SE OXIDAT 32//MITOCHONDRIAL ELECTRON TRANSFER CHAIN//ESTUDOS EST SE OXIDATIVO |
2 | 0.0000160635 | CYP26A1//CYP26//RETINOIC ACID |
3 | 0.0000151549 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
4 | 0.0000111998 | BIOCHEM STEM CELL//BIOL MOL NUTR BIOTECNOL//GRP ENERGY METAB |
5 | 0.0000110728 | KANEMATSU//ISOLATED GLOMERULI//NEPHROL A |
6 | 0.0000103098 | ZENTRUM PHARMAKOL//URINARY NITRITE NITRATE//AIDS PATHOGENESIS MOL THER EUT |
7 | 0.0000093145 | FENRETINIDE//4 HPR//N 4 HYDROXYPHENYL RETINAMIDE |
8 | 0.0000084100 | THY 1 NEPHRITIS//GLOMERULAR BIOENGN UNIT//MESANGIAL CELL |
9 | 0.0000082989 | SMOOTHELIN//SMTNL1//SMEMB |
10 | 0.0000076321 | OPHTHALMIC EMULSION//LACRIMAL FUNCTION//EXPTL PATHOL DIFFERENTIAT CONTROL SECT |